Director Fred S. Zeidman buys 12,500 Bluejay Diagnostics (BJDX) shares at $2.00
Rhea-AI Filing Summary
Bluejay Diagnostics director Fred S. Zeidman bought additional shares of the company’s stock. On March 14, 2026, he purchased 12,500 shares of Bluejay Diagnostics common stock from the company in a private placement at $2.00 per share. Following this transaction, he directly owns 12,500 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 12,500 shares
Net Buy
1 txn
Insider
ZEIDMAN FRED S
Role
Director
Bought
12,500 shs ($25K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 12,500 | $2.00 | $25K |
Holdings After Transaction:
Common Stock — 12,500 shares (Direct)
Footnotes (1)
- F1. On March 14, 2026, Mr. Zeidman purchased 12,500 shares of the issuer's common stock from the issuer in a private placement at a price of $2.00 per share.
Key Figures
Shares purchased: 12,500 shares
Purchase price: $2.00 per share
Shares owned after transaction: 12,500 shares
3 metrics
Shares purchased
12,500 shares
Common Stock bought on March 14, 2026
Purchase price
$2.00 per share
Private placement with issuer
Shares owned after transaction
12,500 shares
Total direct holdings following purchase
Key Terms
private placement, Common Stock, open-market purchase
3 terms
private placement financial
"purchased 12,500 shares of the issuer's common stock from the issuer in a private placement at a price of $2.00 per share"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Bluejay Diagnostics (BJDX) report for Fred S. Zeidman?
Bluejay Diagnostics reported that director Fred S. Zeidman bought 12,500 shares of common stock. The purchase occurred on March 14, 2026, and was made directly from the company in a private placement rather than through the open market.
Is Fred S. Zeidman a director of Bluejay Diagnostics (BJDX)?
Yes, Fred S. Zeidman is identified as a director of Bluejay Diagnostics. The Form 4 indicates his role as a director and shows he engaged in a direct purchase of 12,500 common shares in a private placement on March 14, 2026.
Was the Bluejay Diagnostics (BJDX) insider purchase an open-market trade?
No, the transaction was not an open-market trade. A footnote explains that on March 14, 2026, Fred S. Zeidman purchased 12,500 shares of common stock directly from Bluejay Diagnostics in a private placement at a price of $2.00 per share.